Sort   by:  
 Page size 
UnknownMutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
Not available
S-EPMC3436555 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownCopy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.
Not available
S-EPMC9949586 | biostudies-literature
UnknownPrognostic gene expression signature for high-grade serous ovarian cancer.
Not available
S-EPMC7484370 | biostudies-literature
UnknownIdentification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Not available
S-EPMC3709460 | biostudies-literature
UnknownEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Not available
S-EPMC3848248 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
UnknownWho, if anyone, may benefit from a total hip arthroplasty after a displaced femoral neck fracture?: a post hoc subgroup analysis of the HEALTH trial.
Not available
S-EPMC9422900 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownNovel Textbook Outcomes following emergency laparotomy: Delphi exercise.
Not available
S-EPMC10823418 | biostudies-literature
Sort   by:  
 Page size